Cymbalta

A popular antidepressant, duloxetine (generic Cymbalta), is being recalled due to high levels of nitrosamines, a potential cancer-causing chemical. The FDA reported that Breckenridge Pharmaceutical initiated the recall on June 4, affecting 360,000 bottles of 30-mg and 60-mg delayed-release capsules with specific lot codes and expiration dates. Patients are advised to consult their doctor or pharmacist before discontinuing the medication.

A popular antidepressant, duloxetine (generic Cymbalta), is being recalled due to high levels of nitrosamines, a chemical linked to cancer risk. The FDA reported that Breckenridge Pharmaceutical initiated the recall for specific lot codes and expiration dates of 30-mg and 60-mg delayed-release capsules. The affected medication was distributed nationwide, and patients are advised to consult healthcare professionals before discontinuing use.

A popular antidepressant, duloxetine (generic Cymbalta), is being recalled due to high levels of nitrosamines, a potentially cancer-causing chemical. The FDA announced the recall of nearly 360,000 bottles distributed nationwide by Breckenridge Pharmaceutical, affecting specific lot codes and expiration dates.

The FDA has initiated a recall of Cymbalta antidepressant by Breckenridge Pharmaceutical due to potential cancer-causing substances. Over 14,000 bottles of Duloxetine delayed-release capsules are being recalled for treating depression, anxiety, and fibromyalgia.